UPDATED May 15, 2024
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
LLY | US$787.02 | 3.0% | 79.9% | US$687.9b | US$850.41 | PE115.4x | E27.3% | 0.7% | ||
MRK | US$131.73 | 2.4% | 14.8% | US$325.9b | US$141.64 | PE144.7x | E24.1% | 2.3% | ||
AMGN | US$319.04 | 2.5% | 41.8% | US$167.1b | US$314.65 | PE45.5x | E17.9% | 2.8% | ||
ABBV | US$163.79 | 1.4% | 14.3% | US$285.3b | US$181.55 | PE48.6x | E23.3% | 3.8% | ||
DHR | US$263.46 | 1.6% | 17.0% | US$192.0b | US$272.68 | PE48x | E13.5% | 0.4% | ||
JNJ | US$152.67 | 0.9% | -4.0% | US$364.3b | US$173.26 | PE21.5x | E6.9% | 3.2% | ||
PFE | US$28.82 | 1.6% | -21.6% | US$160.8b | US$31.94 | PS3x | E28.9% | 5.8% | ||
VRTX | US$437.49 | 2.1% | 28.2% | US$110.6b | US$462.55 | PE28.1x | E10.2% | n/a | ||
ZTS | US$173.28 | 2.6% | -3.2% | US$77.1b | US$210.99 | PE33.1x | E8.6% | 1.0% | ||
TMO | US$599.02 | 0.7% | 14.8% | US$227.0b | US$627.27 | PE37.9x | E10.6% | 0.3% | ||
BIIB | US$235.32 | 3.7% | -23.2% | US$33.0b | US$285.92 | PE29.4x | E17.8% | n/a | ||
GRPH | US$22.26 | 580.7% | 861.6% | US$190.4m | n/a | PB7.1x | E36.4% | n/a | ||
A | US$154.08 | 1.9% | 20.6% | US$44.3b | US$150.94 | PE36.5x | E9.0% | 0.6% | ||
VKTX | US$78.01 | 7.6% | 219.6% | US$8.0b | US$108.44 | PB9.2x | E4.7% | n/a | ||
ICLR | US$321.80 | 2.0% | 52.8% | US$26.1b | US$354.14 | PE39x | E14.1% | n/a | ||
MTD | US$1,519.89 | 1.6% | 11.0% | US$32.0b | US$1,317.00 | PE41.7x | E8.3% | n/a | ||
PCVX | US$71.63 | 6.4% | 48.7% | US$7.3b | US$103.14 | PB3.9x | E1.3% | n/a | ||
IQV | US$233.69 | 1.1% | 21.1% | US$42.1b | US$271.44 | PE31.4x | E13.0% | 0% | ||
BGNE | US$164.88 | 2.6% | -28.6% | US$16.8b | US$267.01 | PS6.2x | E60.6% | n/a | ||
NBIX | US$142.00 | 2.5% | 49.1% | US$13.9b | US$158.43 | PE38.7x | E26.5% | n/a | ||
RVMD | US$39.39 | 5.4% | 51.9% | US$6.2b | US$44.82 | PS1423.3x | E10.4% | n/a | ||
MRNA | US$129.06 | 0.6% | 2.8% | US$49.2b | US$138.51 | PS9.6x | E68.8% | n/a | ||
BRKR | US$77.51 | 2.4% | 4.4% | US$11.0b | US$85.70 | PE28.1x | E6.8% | 0.3% | ||
ARWR | US$25.04 | 9.3% | -32.5% | US$2.8b | US$53.77 | PS87.7x | E34.6% | n/a |